Roger P. Smith

No ORCID on file · 7 papers in corpus · active 1984-2018

Study types

  • article 5
  • book-chapter 2

Condition tags

  • dysmenorrhea 2
  • chronic_pelvic_pain 2
  • die_deep_infiltrating 1
book-chapter 2018
·doi:10.1007/978-3-319-71964-1_11
article 2014
·doi:10.1093/humrep/deu205

STUDY QUESTION: What is the safe and pharmacodynamically active dose range for PDC31 (prostaglandin F2α receptor inhibitor) in patients with primary dysmenorrhea (PD)? SUMMARY ANSWER: The 1 mg/kg/h dose of PDC31 appears to be safe and poten…

book-chapter 2005
·doi:10.1016/b978-84-458-1311-9.50093-8
article 1993
·doi:10.1016/s0889-8545(21)00391-0
article 1992
·doi:10.3109/01674829209009201

A specially designed pain questionnaire can assist in the diagnosis and management of patients with ‘chronic pelvic pain’. Questionnaires used generally include information about demographics, a medical, sexual and marital history, an asses…

article 1992
·doi:10.1097/00007611-199212000-00007

Assessment of cases of chronic pelvic pain presents a challenging problem, and many physicians overlook the association of sleep disorders and depression with such pain. We examined these linkages in our chronic pelvic pain clinic, using a …

article 1984
·doi:10.1016/0002-9378(84)90226-6